CIK 0001650664
- Non-accelerated filer
- Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464097528
- Phone
- +1 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- 4 Grant or award EVP, Chief Scientific Officer acquired 9,084 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 4,471 shares (grant or award)
- 4 Grant or award CEO acquired 36,477 shares (grant or award)
- 4 Open-market sale EVP/Chief Medical Officer sold 1,568 shares at $38.33 ($60,101)
- 4 Open-market sale EVP, Chief Business Officer sold 287 shares at $40.61 ($11,655)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale CEO sold 13,805 shares at $38.03 ($525,033)
- 4 Grant or award CEO acquired 36,478 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 2,500 shares at $60.00 ($150,000)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 2,500 shares at $50.00 ($125,000)
- 4 Derivatives Options or other derivatives
- 4 Grant or award EVP, Chief Scientific Officer acquired 32,701 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 8 of 18 · 351 filings